Literature DB >> 15721127

Utility of cardiopulmonary stress testing in assessing disease severity in children with pulmonary arterial hypertension.

Anji T Yetman1, Amy L Taylor, Aimee Doran, D Dunbar Ivy.   

Abstract

This study sought to assess the safety of cardiopulmonary stress testing in 40 children with pulmonary arterial hypertension and to compare exercise responses in this patient cohort with those of a healthy control population. Patients with pulmonary hypertension had significant impairment in aerobic capacity, with a peak oxygen consumption of 20.7 +/- 6.9 versus 35.5 +/- 7.4 ml/kg/min in healthy controls (p <0.0001). Peak oxygen consumption was strongly correlated with invasive measures of disease severity, including pulmonary vascular resistance index (r = -0.6, p = 0.006). Exercise testing can be performed safely in this group of patients and can yield valuable clinical information.

Entities:  

Mesh:

Year:  2005        PMID: 15721127     DOI: 10.1016/j.amjcard.2004.10.056

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.

Authors:  Jennifer L Snow; Steven M Kawut
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 2.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

Review 3.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

4.  Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension.

Authors:  Hong-Da Zhang; Zi-Chao Lv; Li-Ting Wang; Alexander Rothman; Tian-Yu Lian; Yang-Yang He; Yan Wu; Allan Lawrie; Maurice Beghetti; Zhi-Cheng Jing
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

5.  Non-congenital heart disease associated pediatric pulmonary arterial hypertension.

Authors:  D D Ivy; J A Feinstein; T Humpl; E B Rosenzweig
Journal:  Prog Pediatr Cardiol       Date:  2009-12-01

6.  Living at an altitude adversely affects exercise capacity in Fontan patients.

Authors:  Jeffrey R Darst; Marko Vezmar; Brian W McCrindle; Cedric Manlhiot; Amy Taylor; Jennifer Russell; Anji T Yetman
Journal:  Cardiol Young       Date:  2010-09-20       Impact factor: 1.093

7.  Pulmonary arterial hypertension in children: Diagnostic work-up and challenges.

Authors:  E B Rosenzweig; J A Feinstein; T Humpl; D D Ivy
Journal:  Prog Pediatr Cardiol       Date:  2009-12

Review 8.  Pulmonary Hypertension in Children.

Authors:  Dunbar Ivy
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

9.  A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.

Authors:  Dunbar Ivy; Ben T Saji
Journal:  Nihon Shoni Junkanki Gakkai Zasshi       Date:  2010-06-04

10.  Ventilatory efficiency slope correlates with functional capacity, outcomes, and disease severity in pediatric patients with pulmonary hypertension.

Authors:  Christopher M Rausch; Amy Lynne Taylor; Hayley Ross; Stefan Sillau; D Dunbar Ivy
Journal:  Int J Cardiol       Date:  2013-10-11       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.